Back to search

Etoposide Plus Cisplatin With or Without the Combination of 4'-Epidoxorubicin Plus Cyclophosphamide in Treatment of Extensive Small-Cell Lung Cancer: a French Federation of Cancer Institutes Multicenter Phase III Randomized Study

Data up to Jan 2025

Published2001
Citations171
References29
Clinical Trials (1)

Total Citations Per Year

Abstract

References (29)

Nonparametric Estimation from Incomplete Observations

1992 • 45,923 citations

The European Organization for Research and Treatment of Cancer QLQ-C30: A Quality-of-Life Instrument for Use in International Clinical Trials in Oncology

1993 • 14,121 citations

Nonparametric Estimation from Incomplete Observations

1958 • 7,673 citations

Prophylactic Cranial Irradiation for Patients with Small-Cell Lung Cancer in Complete Remission

1999 • 1,607 citations

Twice-Daily Compared with Once-Daily Thoracic Radiotherapy in Limited Small-Cell Lung Cancer Treated Concurrently with Cisplatin and Etoposide

1999 • 1,394 citations

Meta-analysis of the literature or of individual patient data: is there a difference?

1993 • 752 citations

Keynote address on biostatistics and data retrieval.

1973 • 476 citations

Randomized Trial of Cyclophosphamide, Doxorubicin, and Vincristine Versus Cisplatin and Etoposide Versus Alternation of These Regimens in Small-Cell Lung Cancer

1991 • 444 citations

Combination versus single agent chemotherapy: A review of the basis for selection of drug treatment of cancer

1975 • 398 citations

Twenty Years of Phase III Trials for Patients With Extensive-Stage Small-Cell Lung Cancer: Perceptible Progress

1999 • 351 citations

Is there a case for cisplatin in the treatment of small-cell lung cancer? A meta-analysis of randomized trials of a cisplatin-containing regimen versus a regimen without this alkylating agent

2000 • 282 citations

Prospective randomized comparison of high-dose and standard-dose etoposide and cisplatin chemotherapy in patients with extensive-stage small-cell lung cancer.

1994 • 252 citations

Importance of bleomycin in favorable-prognosis disseminated germ cell tumors: an Eastern Cooperative Oncology Group trial.

1995 • 250 citations

A systematic review of the role of etoposide and cisplatin in the chemotherapy of small cell lung cancer with methodology assessment and meta-analysis

2000 • 249 citations

Initial Chemotherapeutic Doses and Survival in Patients with Limited Small-Cell Lung Cancer

1993 • 249 citations

Improving Survival Without Reducing Quality of Life in Small-Cell Lung Cancer Patients by Increasing the Dose-Intensity of Chemotherapy With Granulocyte Colony-Stimulating Factor Support: Results of a British Medical Research Council Multicenter Randomized Trial

2000 • 224 citations

Pretreatment prognostic factors and scoring system in 407 small‐cell lung cancer patients

1987 • 200 citations

Effects of granulocyte-macrophage colony-stimulating factor and dose intensification of V-ICE chemotherapy in small-cell lung cancer: a prospective randomized study of 300 patients.

1998 • 147 citations

Randomized Study of CODE Versus Alternating CAV/EP for Extensive-Stage Small-Cell Lung Cancer: An Intergroup Study of the National Cancer Institute of Canada Clinical Trials Group and the Southwest Oncology Group

1999 • 132 citations

Combined modality induction therapy without maintenance chemotherapy for small cell carcinoma of the lung.

1984 • 114 citations

Competing events determining relapse-free survival in limited small-cell lung carcinoma. The French Cancer Centers' Lung Group.

1992 • 109 citations

Increasing the therapeutic response rates to anticancer drugs by applying the basic principles of pharmacology

1984 • 90 citations

Dose-intensity of a four-drug chemotherapy regimen with or without recombinant human granulocyte-macrophage colony-stimulating factor in extensive-stage small-cell lung cancer: a multicenter randomized phase III study.

1997 • 85 citations

Sequencing and schedule effects of cisplatin plus etoposide in small-cell lung cancer: results of a North Central Cancer Treatment Group randomized clinical trial.

1994 • 69 citations

Application of theoretical models to chemotherapy protocol design.

1986 • 57 citations

Small cell lung cancer.

1986 • 41 citations

The addition of cisplatin to cyclophosphamide-doxorubicin-etoposide combination chemotherapy in the treatment of patients with small cell lung carcinoma

1999 • 34 citations

Causes of treatment failure and death in carcinoma of the lung.

1981 • 27 citations

Chemotherapy of small cell lung cancer

1991 • 25 citations

Cited By (0)

No citing papers found in database

Etoposide Plus Cisplatin With or Without the Combination of 4'-Epidoxorubicin Plus… (2001) – JNCI Journal of the National Cancer Institute | Metascience Observatory Explorer